CD274 and nasopharyngeal carcinoma: Given NPC’s high PD-L1 expression and significant lymphocyte infiltration, immunotherapy has shown potential, particularly with EBV-directed vaccinations, adoptive T-cell therapy, and immune checkpoint inhibitors.